세계의 정밀의료 시장 : 예측(2025-2030년)

Precision Medicine Market Size:

The precision medicine market is expected to grow from USD 109.297 billion in 2025 to USD 186.506 billion in 2030, at a CAGR of 11.28%.

Precision Medicine Market Report Summary

Market Overview

Precision medicine, also known as personalized medicine, represents a medical approach where doctors select treatments based on genetic understanding of individual patients. The market is primarily driven by the increasing prevalence of chronic diseases including cardiovascular diseases, obesity, and related conditions. This personalized approach to treatment has gained significant traction as healthcare systems seek more targeted and effective therapeutic interventions.

The market growth is substantially influenced by the global burden of chronic diseases. Cardiovascular diseases represent one of the major causes of death worldwide, accounting for approximately 31% of global deaths. Most cardiovascular-related deaths result from strokes and heart attacks, creating substantial demand for precision medicine approaches that can provide more targeted prevention and treatment strategies.

Chronic Disease Applications

Cognitive Disorders and Alzheimer's Disease

Alzheimer's disease and related cognitive disorders represent significant applications for precision medicine technology. Current projections indicate substantial growth in affected populations, with estimates suggesting the number of Americans living with Alzheimer's disease could reach approximately 14 million by 2050. This demographic trend drives sustained market demand for precision medicine solutions targeting cognitive disorders.

Research developments have revealed important insights into treatment effectiveness. Scientists at the University of Buffalo discovered that a human gene present in 75% of the American population contributes to why certain Alzheimer's disease medications fail in human studies despite showing promising results in animal studies. This discovery highlights the importance of precision medicine approaches over conventional treatments and demonstrates the market potential for genetically-informed therapeutic strategies.

Diabetes Treatment Applications

Diabetes represents another major driver for precision medicine market growth. The National Institute of Diabetes and Digestive and Kidney Diseases has made precision medicines a major priority for its Diabetes Genomics and Genetics Program. The program aims to identify intergenic regions and genes that provide protection against type 1 and type 2 diabetes.

Medical institutions are implementing precision medicine techniques for diabetes treatment with promising results. Massachusetts General Hospital research demonstrated that interventions focused on individuals' genetic profiles and data successfully reduced type 2 diabetes risk, validating the precision medicine approach for diabetes management.

Digital Health Integration

Healthcare systems are expanding precision medicine capabilities through digital health programs. The Louisiana Health system (Ochsner Health) provides comprehensive digital health solutions to patients and has made substantial investments in developing direct-to-consumer telemedicine care services and delivery systems. The organization plans to expand telehealth services for ICU, psychiatry, and stroke care applications over the next decade, demonstrating the integration of precision medicine with digital healthcare delivery.

Cancer Treatment Applications

Cancer treatment represents a primary driver for precision medicine market expansion. Cancer ranks as the second major cause of death worldwide, with an estimated 9.6 million deaths annually. Approximately 70% of cancer deaths occur in lower and middle-income countries, highlighting global market opportunities for precision medicine solutions.

Cancer treatment applications are particularly suited for precision medicine approaches because genetic changes constantly occur in cancer development. Scientists are working to identify and conduct genetic tests that determine optimal treatment approaches for individual cancer cases and tumors. This personalized approach addresses the heterogeneity of cancer presentations and improves treatment outcomes through targeted therapeutic selection.

Research institutions are developing comprehensive databases to accelerate precision medicine therapy development. Collaborative efforts involving multiple organizations have compiled databases of head and neck cancers to speed development and production of precision medicine therapies. These databases provide clarification of key cancer-associated proteins and genes, resulting in advancement of cancer pathway understanding.

Technological Advancement and Partnerships

The precision medicine market continues evolving through strategic partnerships and technological innovation. Genetic sequencing represents a fundamental component of precision medicine development, with industry collaborations focused on advancing complete genomic profiling capabilities. These partnerships drive development of novel and innovative precision medicine solutions across multiple therapeutic areas.

Market Outlook

The precision medicine market demonstrates strong growth potential driven by chronic disease prevalence, technological advancement, and healthcare system adoption of personalized treatment approaches. The integration of genetic understanding with clinical care creates opportunities for more effective, targeted therapeutic interventions across diverse medical conditions.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2022 to 2024 & forecast data from 2025 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Global Precision Medicine Market Segments:

By Technology

• Data Analytics (including AI/ML)
• Bioinformatics
• Gene Sequencing
• Genomics/Functional Genomics
• Proteomics
• Metabolomics
• Digital Health Technologies
• Companion Diagnostics

By Application

• Oncology
• Central Nervous System
• Immunology
• Cardiovascular
• Rare Diseases
• Infectious Diseases
• Respiratory Diseases
• Metabolic Disorders
• Hematology

By Geography

• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• United Kingdom
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Others
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Thailand
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL PRECISION MEDICINE MARKET BY TECHNOLOGY

• 5.1. Introduction
• 5.2. Data Analytics (including AI/ML)
• 5.3. Bioinformatics
• 5.4. Gene Sequencing
• 5.5. Genomics/Functional Genomics
• 5.6. Proteomics
• 5.7. Metabolomics
• 5.8. Digital Health Technologies
• 5.9. Companion Diagnostics

6. GLOBAL PRECISION MEDICINE MARKET BY APPLICATION

• 6.1. Introduction
• 6.2. Oncology
• 6.3. Central Nervous System
• 6.4. Immunology
• 6.5. Cardiovascular
• 6.6. Rare Diseases
• 6.7. Infectious Diseases
• 6.8. Respiratory Diseases
• 6.9. Metabolic Disorders
• 6.10. Hematology

7. GLOBAL PRECISION MEDICINE MARKET BY GEOGRAPHY

• 7.1. Introduction
• 7.2. North America
  • 7.2.1. USA
  • 7.2.2. Canada
  • 7.2.3. Mexico
• 7.3. South America
  • 7.3.1. Brazil
  • 7.3.2. Argentina
  • 7.3.3. Others
• 7.4. Europe
  • 7.4.1. Germany
  • 7.4.2. France
  • 7.4.3. United Kingdom
  • 7.4.4. Spain
  • 7.4.5. Others
• 7.5. Middle East and Africa
  • 7.5.1. Saudi Arabia
  • 7.5.2. UAE
  • 7.5.3. Others
• 7.6. Asia Pacific
  • 7.6.1. China
  • 7.6.2. India
  • 7.6.3. Japan
  • 7.6.4. South Korea
  • 7.6.5. Indonesia
  • 7.6.6. Thailand
  • 7.6.7. Others

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 8.1. Major Players and Strategy Analysis
• 8.2. Market Share Analysis
• 8.3. Mergers, Acquisitions, Agreements, and Collaborations
• 8.4. Competitive Dashboard

9. COMPANY PROFILES

• 9.1. Thermo Fisher Scientific Inc.
• 9.2. AstraZeneca plc
• 9.3. F. Hoffmann-La Roche Ltd
• 9.4. Pfizer Inc.
• 9.5. Nordic Bioscience A/S
• 9.6. Medtronic
• 9.7. Novartis AG
• 9.8. QIAGEN
• 9.9. Quest Diagnostics Incorporated
• 9.10. Bristol Myers Squibb

10. APPENDIX

• 10.1. Currency
• 10.2. Assumptions
• 10.3. Base and Forecast Years Timeline
• 10.4. Key benefits for the stakeholders
• 10.5. Research Methodology
• 10.6. Abbreviations

LIST OF FIGURES

LIST OF TABLES